Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China flag China · Delayed Price · Currency is CNY
5.68
+0.12 (2.16%)
May 8, 2026, 3:04 PM CST

SHE:002252 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
6,8437,3408,1747,9626,5664,285
Other Revenue
8.438.432.851.571.323.01
6,8527,3488,1767,9646,5674,288
Revenue Growth (YoY)
-15.68%-10.13%2.67%21.27%53.16%55.26%
Cost of Revenue
4,3724,6584,8724,7353,6782,069
Gross Profit
2,4802,6903,3043,2292,8892,219
Selling, General & Admin
829.32803.9867.79712.75706.48616.64
Research & Development
234.73223.37250.9173.74145.71129.02
Other Operating Expenses
50.9546.5448.6631.4932.8123.05
Operating Expenses
1,1211,0941,211912.68900.18756.75
Operating Income
1,3591,5962,0932,3161,9891,462
Interest Expense
-64.7-44.11-0.22-0.12-0.26-0.47
Interest & Investment Income
408.76422.59634.16135.38510.69466.09
Currency Exchange Gain (Loss)
16.7916.79-85.01-43.34-56.5511.28
Other Non Operating Income (Expenses)
-7.86-11.27-0.08-0.42-1.42-1.91
EBT Excluding Unusual Items
1,6871,9802,6422,4082,4411,937
Impairment of Goodwill
-94.02-94.02---197.02-361.19
Gain (Loss) on Sale of Investments
----196.8918.38-42.76
Gain (Loss) on Sale of Assets
21.1321.16-1.61-0.010.23-1.35
Asset Writedown
3.970.07-13.23-4.31-2.47-9.26
Other Unusual Items
-7.08-1.73-7.07-2.5213.1116.54
Pretax Income
1,6111,9062,6202,2042,2741,539
Income Tax Expense
284.98328.93426.31426.65400.61250.09
Earnings From Continuing Operations
1,3261,5772,1941,7771,8731,289
Minority Interest in Earnings
0.560.42-0.52.047.095.56
Net Income
1,3271,5772,1931,7791,8801,295
Net Income to Common
1,3271,5772,1931,7791,8801,295
Net Income Growth
-33.75%-28.10%23.25%-5.35%45.24%-2.21%
Shares Outstanding (Basic)
6,5586,5786,6176,5916,7416,741
Shares Outstanding (Diluted)
6,5636,5836,6176,5916,7416,741
Shares Change (YoY)
-0.89%-0.51%0.39%-2.23%-5.28%
EPS (Basic)
0.200.240.330.270.280.19
EPS (Diluted)
0.200.240.330.270.280.19
EPS Growth
-32.77%-27.35%22.22%-3.19%46.80%-8.09%
Free Cash Flow
-1,405-713.52-889.21,8271,5001,089
Free Cash Flow Per Share
-0.21-0.11-0.130.280.220.16
Dividend Per Share
0.0480.0480.0700.0300.0300.028
Dividend Growth
-31.00%-31.00%133.33%-7.14%12.00%
Gross Margin
36.19%36.61%40.41%40.54%43.99%51.75%
Operating Margin
19.83%21.72%25.60%29.09%30.29%34.10%
Profit Margin
19.36%21.46%26.82%22.34%28.63%30.19%
Free Cash Flow Margin
-20.51%-9.71%-10.88%22.94%22.84%25.41%
EBITDA
1,5841,8182,2992,4772,1691,616
EBITDA Margin
23.13%24.74%28.11%31.10%33.03%37.69%
D&A For EBITDA
225.76221.71205.52160.39180.33154.07
EBIT
1,3591,5962,0932,3161,9891,462
EBIT Margin
19.83%21.72%25.60%29.09%30.29%34.10%
Effective Tax Rate
17.69%17.26%16.27%19.36%17.62%16.25%
Revenue as Reported
---7,9646,5674,288
Advertising Expenses
-108.83193.47143.4193.23169.52
Source: S&P Global Market Intelligence. Standard template. Financial Sources.